<DOC>
	<DOCNO>NCT01023646</DOCNO>
	<brief_summary>The purpose study determine variability glycemic index determination individual food food combination . The study also evaluate change insulin free fatty acid level , plasma lipid lipoprotein profile , C-reactive protein-a marker inflammation glycosylated hemoglobin- marker glucose metabolism five-hour period eat food food . Additionally , supplementary data variation oral sensation , habitual food intake , food preference gene mediate sensory perception dietary behavior ( support grant Tufts Ross Aging Initiative ) relate outcomes present study .</brief_summary>
	<brief_title>Glycemic Index - Variability Among Individuals</brief_title>
	<detailed_description>The objective proposal investigate intra-individual reproducibility ( within individual , repeatedly measure ) inter-individual variability ( among individual ) glycemic index ( GI ) glycemic load ( GL ) value determination individual food food combination . The specific aim accomplish objective evaluate reproducibility variability GI value determination volunteer differ biologic characteristic - body mass index ( BMI ) , age gender ; assess effect macronutrient amount combination , fiber variability GI GL value determination ; assess effect prior meal macronutrient composition ( 'second meal ' effect ) GI value determination ; relate data chronic disease risk factor monitor prior intervention period . These aim accomplish assess intra-individual reproducibility inter-individual variability repeat GI value determination white bread , commonly use reference food , relative glucose , volunteer select represent range BMI 's ( 18-24.9 , 25-29.9 , 30-35 ) age ( 18-49.9 , 50-85 ) , basis gender , relate data body composition insulin sensitivity ( Phase I ) . This work extend address issue relate variability potentially introduce difference macronutrient fiber combination load ( Phase II ) , finally 'second meal ' effect ( Phase III ) . Prior set food challenge ( glucose test food [ ] random order ) volunteer characterize basis fast HbA1c ; lipid lipoproteins ; insulin , glucose C-reactive protein . During 5-hour challenge ( sample 0 , 15 , 30 , 45 , 60 , every 30 minute thereafter ) volunteer monitor change blood glucose , insulin , triglyceride , total , low density lipoprotein high density lipoprotein cholesterol , non-esterified fatty acid level . Additionally , supplementary data variation oral sensation , habitual food intake , food preference gene mediate sensory perception dietary behavior ( support grant Tufts Ross Aging Initiative ) relate outcomes present study . The concept GI GL public domain suggest concept incorporate U.S. federal dietary guidance ( U.S. Dietary Guidelines Dietary References Intakes ) formulate promote health reduce chronic disease risk . This proposal address understudied area additional information would useful order determine whether GI GL use classify food individual basis , suggest , formulate dietary guidance general population .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>For Phase 1 ( Study 1 ) total seventy five volunteer include study . This study conduct adult men woman ( 1885 ) free know chronic disease BMI 18 35 kg/m2 . For Phase 2 ( Studies 2 , 3 , 4 , 5 ) total 80 volunteer include , 20 volunteer per study . Phase 2 study conduct adult men woman ( 50 85 ) free know chronic disease BMI 25 35 kg/m2 . For Phase 3 ( Study 6 ) total 20 volunteer include study . Phase 3 study conduct adult men woman ( 5085 ) free know chronic disease BMI 25 35 kg/m2 . Exclusion criterion : BMI ≥ 35 kg/m2 Phase I , BMI ≤ 25 ≥ 35 kg/m2 Phase II III Renal disease , define history chronic kidney disease glomerular filtration rate &lt; 60 ml.min/1.73 m2 calculate screen blood test . Liver disease , define history chronic hepatitis B C , cholestatic cirrhotic liver disease , nonalcoholic fatty liver disease , elevation serum glutamate pyruvate transaminase ( SGPT ) serum glutamate oxaloacetate transaminase ( SGOT ) great 1.5 time upper limit normal screening , bilirubin great 2 mg/dL ( absence benign cause elevate bilirubin Gilbert 's syndrome ) screening , albumin low limit normal . Untreated hypertension , define systolic blood pressure ( SBP ) &gt; 140 mm diastolic blood pressure ( DBP ) &gt; 90 mm . Irritable bowel syndrome . Malabsorptive disorder inflammatory bowel disease . Disorders esophageal gastrointestinal motility , previous esophageal gastric resection . History chronic pancreatitis , history acute pancreatitis within last year . Hypothyroidism hyperthyroidism , define screen thyroidstimulating hormone ( TSH ) outside normal range . Anemia , define screen hematocrit 34 % woman 38 % men . Smoking within past 6 month . Diabetes . Fasting glucose ≥ 125 mg/dL . Pregnancy . Breastfeeding . History polycystic ovary syndrome History autoimmune connective tissue disorder associate chronic inflammation , rheumatoid arthritis . Alcohol consumption &gt; 7 drinks/week . Use medication supplement know affect glucose metabolism . Use medication supplement know affect lipid metabolism . Established cardiovascular disease ( myocardial infarction , stroke , heart failure , coronary artery . bypass graft , stenosis &gt; 50 % , peripheral arterial disease ) . Unwillingness adhere study protocol . Weight gain loss 15 lb within 6 month prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Glycemic Index</keyword>
	<keyword>Glycemic Load</keyword>
	<keyword>Glucose</keyword>
	<keyword>Insulin</keyword>
	<keyword>Lipoproteins</keyword>
	<keyword>Free fatty acid</keyword>
</DOC>